Loss-of-function genetic diseases and the concept of pharmaceutical targets.

Abstract excerpt

The biomedical world relies heavily on the definition of pharmaceutical targets as an essential step in the drug design process. It is therefore tempting to apply this model to genetic diseases as well. However, whereas the model applies well to gain-of-function genetic diseases, it is less suited to most loss-of-function genetic diseases. Most common diseases, as well as gain-of-function genetic diseases, are...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Delivery Systems
• Share to Drug Design
• Share to Genetic Diseases, Inborn